Angiotensin; Related Peptides Patents (Class 930/40)
  • Patent number: 8536231
    Abstract: The present invention provides methods and pharmaceutical formulations for treating diabetic foot ulcers.
    Type: Grant
    Filed: May 9, 2012
    Date of Patent: September 17, 2013
    Inventors: Kathleen E. Rodgers, Gere S. diZerega
  • Patent number: 8207233
    Abstract: The present invention provides methods and pharmaceutical formulations for treating diabetic foot ulcers.
    Type: Grant
    Filed: February 1, 2012
    Date of Patent: June 26, 2012
    Assignee: University of Southern California
    Inventors: Kathleen E. Rodgers, Gere S. diZerega
  • Patent number: 8207234
    Abstract: The present invention provides methods and pharmaceutical formulations for treating diabetic foot ulcers.
    Type: Grant
    Filed: April 6, 2012
    Date of Patent: June 26, 2012
    Assignee: University of Southern California
    Inventors: Kathleen E. Rodgers, Gere S. diZerega
  • Patent number: 7148034
    Abstract: The present invention relates to a process of preparing a whey protein hydrolysate from a WPI substrate having improved flavour, functionality and ACE-I inhibiting properties.
    Type: Grant
    Filed: September 11, 2001
    Date of Patent: December 12, 2006
    Assignee: New Zealand Dairy Board
    Inventors: Ralf-Christian Schlothauer, Linda May Schollum, Julian Robert Reid, Stephanie Adele Harvey, Alistair James Carr, Rachel Lois Fanshawe
  • Patent number: 7125702
    Abstract: The invention is a process for the preparation of angiotensin converting enzyme (ACE) inhibitors and the use thereof.
    Type: Grant
    Filed: November 28, 2005
    Date of Patent: October 24, 2006
    Assignee: Council of Scientific and Industrial Research
    Inventors: Lalitha Ramakrishna Gowda, Appu Rao Gopal Rao Appu Rao, Vishweshwariah Prakash
  • Patent number: 6919314
    Abstract: The invention relates to a partial hydrolysate of whey protein which contains bioactive peptides but does not have a bitter flavor. The hydrolysate is carried out using selective enzymes which produce the active peptides and is terminated at a degree of hydrolysis before substantial bitter flavors are created. There are also described novel peptides and a method of reducing systolic blood pressure through the administration of the peptides.
    Type: Grant
    Filed: June 14, 1999
    Date of Patent: July 19, 2005
    Assignee: New Zealand Dairy Board
    Inventors: Ralf-Christian Schlothauer, Linda May Schollum, Anne Maria Singh, Julian Robert Reid